Hudson Thomas J
SEC CIK 1781947 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | SVP, R, D AND CSO | 107.3K | — | — | 6 | 2022-02-17 | 2024-02-28 |
Most active insiders at ABBV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Siatis Perry C | EVP, GC AND Sec | — | $9.52M |
| 2 | Donoghoe Nicholas | EVP, CHIEF BUS, STRAT Off | — | $8.18M |
| 3 | Purdue David Ryan | SVP, Ctrl | — | $1.22M |
| 4 | Crum Demetris D | EVP, Chief HR Off | — | — |
| 5 | Thakkar Roopal | EVP, CSO, R, D | — | — |
| 6 | Quaggin Susan E | Dir | — | — |
| 7 | Reents Scott T | EVP, CFO | — | — |
| 8 | Davis Jennifer L. | Dir | — | — |
| 9 | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | — | — |
| 10 | MEYER MELODY B | Dir | — | — |
Hudson Thomas J made no open-market trades at ABBV in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-01 | 2024-02-28 | ABBV | AbbVie | Hudson Thomas J | SVP, CSO, Gbl RESEARCH | F - Tax | $178.99 | -20.6K | 107.3K | -16% | -$3.69M | |
| DM | 2024-02-20 | 2024-02-15 | ABBV | AbbVie | Hudson Thomas J | SVP, CSO, Gbl RESEARCH | A - Grant | $0.00 | +46.6K | 127.9K | +57% | $0 |
| 2023-03-02 | 2023-02-28 | ABBV | AbbVie | Hudson Thomas J | SVP, R, D AND CSO | F - Tax | $154.28 | -27.9K | 81.3K | -26% | -$4.31M | |
| DM | 2023-02-21 | 2023-02-16 | ABBV | AbbVie | Hudson Thomas J | SVP, R, D AND CSO | A - Grant | $0.00 | +63.0K | 86.9K | +264% | $0 |
| 2022-03-01 | 2022-02-25 | ABBV | AbbVie | Hudson Thomas J | SVP, CSO, R, D | F - Tax | $149.54 | -13.4K | 46.2K | -22% | -$2.01M | |
| DM | 2022-02-22 | 2022-02-17 | ABBV | AbbVie | Hudson Thomas J | SVP, CSO, R, D | A - Grant | $0.00 | +30.3K | 59.6K | +103% | $0 |
Purchase Sale Sale after option exercise All abbreviations